Trilo Therapeutics

San Francisco, United States

Trilo Therapeutics is developing best-in-class peptide-drug conjugates that address the dose-limiting toxicity of current generation ADCs.

$1.7M raised

Dec 2022

Seed

Biotechnology Medical Pharmaceutical

Top Investors

National Science Foundation

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Trilo Therapeutics

How much funding has Trilo Therapeutics raised?

Trilo Therapeutics has raised $1.7M in total funding. The most recent round was Seed. The last funding was announced in December 2022.

Who are Trilo Therapeutics's investors?

Trilo Therapeutics's investors include National Science Foundation.

Where is Trilo Therapeutics headquartered?

Trilo Therapeutics is headquartered in San Francisco, United States.

What does Trilo Therapeutics do?

Trilo Therapeutics is developing best-in-class peptide-drug conjugates that address the dose-limiting toxicity of current generation ADCs.

What stage is Trilo Therapeutics at?

Trilo Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 1, 2022.

MLA

"Trilo Therapeutics — Funding & Investors." VCBacked, December 1, 2022, https://www.vcbacked.co/company/trilo-therapeutics. Accessed July 5, 2026.

APA

VCBacked. (2022). Trilo Therapeutics — Funding & Investors. Retrieved July 5, 2026, from https://www.vcbacked.co/company/trilo-therapeutics

Wikipedia (cite web)

{{cite web |title=Trilo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/trilo-therapeutics |website=VCBacked |access-date=July 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 1, 2022.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K